Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Portola Pharmaceuticals
Pharma
AZ to pull bleeding reversal agent after FDA flags risk imbalance
Andexxa is slated to be pulled from the market in the coming days. The FDA said it "considers the risks of the product to outweigh its benefits."
Eric Sagonowsky
Dec 19, 2025 1:12pm
SEC charges former Alexion VP Joseph Dupont with insider trading
Jun 30, 2023 8:40am
Activist investor blasts Alexion's $1.4B Portola buyout
May 12, 2020 1:20pm
Alexion bets $1.4B on Portola's laggard bleeding drug Andexxa
May 5, 2020 11:08am
Production of Portola's Andexxa underway—News of Note
Feb 7, 2019 12:00am
Portola finally wins FDA nod for commercial production of Adexxa
Jan 2, 2019 10:33am
